Zevra Therapeutics, Inc. Revenue 2013–2025
Zevra Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Zevra Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 36.2 M, a 77.54% increase year-over-year.
- Zevra Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 108.6 M, a 650.59% increase year-over-year.
- Zevra Therapeutics, Inc. annual revenue for 2025 was 106.5 M, a 350.91% increase from 2024.
- Zevra Therapeutics, Inc. annual revenue for 2024 was 23.6 M, a 14.02% decrease from 2023.
- Zevra Therapeutics, Inc. annual revenue for 2023 was 27.5 M, a 170.26% increase from 2022.
- Zevra Therapeutics, Inc. annual revenue for 2022 was 10.2 M.
Zevra Therapeutics, Inc. (ZVRA) — Frequently Asked Questions
Zevra Therapeutics, Inc. (ZVRA) is a publicly traded US company. It has a market capitalization of $743M. In fiscal 2025 it reported revenue of $106M and net income of $83M. Explore ZVRA's stock price, financial statements, earnings history, margins and key ratios below.
What is Zevra Therapeutics, Inc.'s market cap?
Zevra Therapeutics, Inc. (ZVRA) has a market capitalization of $743M.
What is the ZVRA stock price?
ZVRA trades at $12.97 (-3.93% on the day).
How much revenue does Zevra Therapeutics, Inc. make?
Zevra Therapeutics, Inc. reported revenue of $106M in fiscal 2025.
Is ZVRA profitable?
In fiscal 2025, Zevra Therapeutics, Inc. reported net income of $83M.